Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Theravance Biopharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 119 | 1 | 116 | −2 |
| Shares | 60.7M | 91.7K | 59.3M | −1.22M (−2.0%) |
| Value | $448.8M | $678.0K | $655.6M | +$207.5M (+46.3%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Theravance Biopharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Weiss Asset Management LP | 2,601,778 | $28.8M | 0.67% |
| PDT Partners, LLC | 111,379 | $1.23M | 0.09% |
| Brandywine Global Investment Management, LLC | 111,100 | $1.23M | 0.01% |
| HRT Financial LP | 37,553 | $414.0K | 0.00% |
| Two Sigma Investments, LP | 35,066 | $387.0K | 0.00% |
| Bank of Nova Scotia | 25,483 | $282.0K | 0.00% |
| Ensign Peak Advisors, Inc | 24,830 | $274.0K | 0.00% |
| Trexquant Investment LP | 20,729 | $229.0K | 0.01% |
| Quantamental Technologies LLC | 12,664 | $140.0K | 0.07% |
| Jump Financial, LLC | 11,900 | $131.0K | 0.01% |
| Janus Henderson Group PLC | 10,999 | $122.0K | 0.00% |
| Citadel Advisors LLC | 10,646 | $117.0K | 0.00% |
| Teacher Retirement System of Texas | 10,423 | $115.0K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,022 | $110.0K | 0.00% |
| Cutler Group LP | 8,623 | $95.0K | 0.01% |
| Allworth Financial LP | 1,130 | $12.0K | 0.00% |
| TCI Wealth Advisors, Inc. | 515 | $6.00K | 0.00% |
| Rockefeller Capital Management L.P. | 625 | $6.00K | 0.00% |
| Captrust Financial Advisors | 369 | $4.00K | 0.00% |
| Private Capital Group, LLC | 136 | $2.00K | 0.00% |
| Plante Moran Financial Advisors, LLC | 20 | $0 | 0.00% |
Sold out (23)
Institutions that held Theravance Biopharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Rock Springs Capital Management LP | 687,500 | $5.09M |
| Clearline Capital LP | 577,800 | $4.28M |
| Tri Locum Partners LP | 129,192 | $956.0K |
| Pura Vida Investments, LLC | 100,000 | $740.0K |
| Hennion & Walsh Asset Management, Inc. | 62,546 | $463.0K |
| Blueshift Asset Management, LLC | 53,127 | $393.0K |
| Davenport & Co LLC | 34,000 | $252.0K |
| Campbell & CO Investment Adviser LLC | 27,200 | $201.0K |
| Laurion Capital Management LP | 27,095 | $201.0K |
| Principal Financial Group Inc | 24,799 | $184.0K |
| Occudo Quantitative Strategies LP | 23,958 | $177.0K |
| Palisade Capital Management LLC | 22,000 | $163.0K |
| Engineers Gate Manager LP | 18,482 | $137.0K |
| Diversified Trust Co | 14,721 | $109.0K |
| ExodusPoint Capital Management, LP | 14,791 | $109.0K |
| Handelsbanken Fonder AB | 13,516 | $100.0K |
| Rafferty Asset Management, LLC | 12,649 | $94.0K |
| Nisa Investment Advisors, LLC | 7,000 | $52.0K |
| Penserra Capital Management LLC | 1,685 | $12.0K |
| Point72 Hong Kong Ltd | 775 | $6.00K |
| Nomura Holdings Inc | 352 | $3.00K |
| Massmutual Trust Co FSB | 39 | $0 |
| Kowal Investment Group, LLC | 20 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Theravance Biopharma, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Zazove Associates LLC | 91,669 | $678.0K |